Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials

Emmanuel Weiss, Jean‐François Timsit(Université Claude Bernard Lyon 1), Andrew F. Shorr(Washington Hospital), Jeff Alder(Bayer (United States)), Léonardo Pagani(Ospedale di Bolzano), Marin H. Kollef(Washington University in St. Louis), Carlos M. Luna, Ignacio Martín‐Loeches(St. James's Hospital), John Rex(Princeton University), Matteo Bassetti(Ospedale Policlinico San Martino), Richard G. Wunderink(Northwestern University), Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Marc Engelhardt(Basilea Pharmaceutica (Switzerland)), Santiago Ewig(Augusta-Kranken-Anstalt), Lucy B. Palmer(State University of New York), Marc J. M. Bonten(Utrecht University), Philippe Prokocimer(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeffrey Lipman(The University of Queensland), Jean‐Ralph Zahar(Inserm), Karim Asehnoune(Inserm), Philippe Eggimann(University Hospital of Lausanne), Visanu Thamlikitkul(Siriraj Hospital), George Dimοpoulos(National and Kapodistrian University of Athens), George H. Talbot, Laurent Papazian(Institut Régional d'Administration de Bastia), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Garyphallia Poulakou, Jean Chastre(Inserm), Jan J. De Waele(Ghent University Hospital)
Clinical Infectious Diseases
January 26, 2019
Cited by 49


Related Papers